The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Toll-like receptor 4-mediated activation of murine mast cells
Abstract
Toll-like receptors (TLRs) are a family of pattern recognition receptors that are critical for cellular responses to a variety of bacterial, viral, and fungal products. Mast cells are important to host survival in a number of models of bacterial infection and might act as sentinel cells in host defense. We therefore examined the expression of TLRs and associated molecules by murine bone marrow-derived mast cells (BMMCs). BMMCs and the murine mast cell line MC/9 expressed mRNA for TLR2, TLR4, and TLR6 but not TLR5 and for both adapter molecule MD-2 and signaling molecule MyD88 but lacked surface CD14. After activation with the TLR2- and TLR4-dependent stimuli Staphylococcus aureus-derived peptidoglycan and Escherichia coli-derived lipopolysaccharide (LPS), respectively, mast cells produced significant levels of interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α). To determine whether mast cells require TLR4 for cellular responses to LPS, mast cells were derived from the bone marrow cells of C3H/HeJ and C57Bl/10ScNCr mice containing a point mutation and a null mutation, respectively, in TLR4. Using these models, we demonstrated that the BMMC IL-6 and TNF-α responses to LPS were completely dependent on functional TLR4 with no significant LPS response observed in its absence. These findings have important implications for the mechanism of mast cell responses to pathogens and their products and suggest that different TLR4-expressing cells might have different thresholds for activation with LPS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
Human Toll-Like Receptors Mediate Cellular Activation by Mycobacterium tuberculosis
Means, T. K., Wang, S., Lien, E., Yoshimura, A., Golenbock, D. T., & Fenton, M. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.3920 · Cited by 804 · cited 1×
“TLR2 is required for responses to products from gram-positive bacteria [29, 57], Mycobacterium tuberculosis [58], spirochetes [59], and yeasts [60].”
Background
Cited by
Takeda, K., Kaisho, T., & Akira, S. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141126 · Cited by 6,143
De Filippo, K., Dudeck, A., Hasenberg, M., Nye, E., van Rooijen, N., Hartmann, K., Gunzer, M., Roers, A., & Hogg, N. (2013) · Blood · doi:10.1182/blood-2013-02-486217 · Cited by 880
Mast-cell responses to pathogens
Marshall, J. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1460 · Cited by 861
Self-citationLipopolysaccharide recognition: CD14, TLRs and the LPS-activation cluster
Triantafilou, M., & Triantafilou, K. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02233-0 · Cited by 730
Toll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Mast Cell Mediators: Their Differential Release and the Secretory Pathways Involved
Moon, T. C., Befus, A. D., & Kulka, M. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00569 · Cited by 432
Di Nardo, A., Vitiello, A., & Gallo, R. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.5.2274 · Cited by 405
Kulka, M., Alexopoulou, L., Flavell, R. A., & Metcalfe, D. D. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.049 · Cited by 351
McCurdy, J. D., Olynych, T. J., Maher, L. H., & Marshall, J. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.4.1625 · Cited by 349
Self-citationToll‐like receptor 2 (TLR2) and TLR4 differentially activate human mast cells
Varadaradjalou, S., Féger, F., Thieblemont, N., Hamouda, N. B., Pleau, J., Dy, M., & Arock, M. (2003) · European Journal of Immunology · doi:10.1002/eji.200323830 · Cited by 291
Matsushima, H., Yamada, N., Matsue, H., & Shimada, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.1.531 · Cited by 270
TLR signaling in mast cells: common and unique features
Sandig, H., & Bulfone-Paus, S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00185 · Cited by 268
Regulation of Mast Cell Responses in Health and Disease
Gilfillan, A. M., & Beaven, M. A. (2011) · Critical Reviews™ in Immunology · doi:10.1615/critrevimmunol.v31.i6.30 · Cited by 259
Sutherland, R. E., Olsen, J. S., McKinstry, A., Villalta, S. A., & Wolters, P. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5598 · Cited by 155
“Depending on conditions, mast cells make low levels of IL-6 constitutively (29, 33, 36) and increase its production in response to various stimuli such as SCF (37), PGE2 (38, 39), and IgE (30), TLR2 (40), or TLR4 (40, 41) receptor activation in rodent mast cells and IgE receptor activation (34, 42) and IL-1 (43) in hu…”
BackgroundNew perspectives on the origins and heterogeneity of mast cells
St. John, A. L., Rathore, A. P. S., & Ginhoux, F. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00731-2 · Cited by 126
Mast Cells in Allergic and Inflammatory Diseases
Sismanopoulos, N., Delivanis, D.-A., Alysandratos, K.-D., Angelidou, A., Therianou, A., Kalogeromitros, D., & C. Theoharides, T. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212800165997 · Cited by 87
Sato, H., Zhang, L. S., Martinez, K., Chang, E. B., Yang, Q., Wang, F., Howles, P. N., Hokari, R., Miura, S., & Tso, P. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.07.009 · Cited by 75
Lifetime modulation of the pain system via neuroimmune and neuroendocrine interactions
Zouikr, I., & Karshikoff, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00276 · Cited by 45
Metadata
- Authors
- McCurdy, J. D., Lin, T.-J., & Marshall, J. S.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-12-01
- Volume
- 70
- Issue
- 6
- Pages
- 977-984
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2097895350
- Cited by
- 209
- References
- 2
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.